Grace Therapeutics amends severance for CEO (12-18 mo) and 4 execs (6 mo) as of Jan 10, 2026

Grace Therapeutics, Inc.

CEO Prashant Kohli gets 12 mo base salary (no CIC) or 18 mo base+target bonus (CIC) plus COBRA.
Four other executives get 6 mo base salary (no CIC) or 6 mo base+target bonus (CIC) plus COBRA.
Unvested equity forfeited on termination without Cause absent CIC; fully vests if terminated/resigned within 12 mo after CIC.
Amendments effective January 10, 2026; prior severance terms superseded.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.